taxonomy (1)
protein (1)
source (3)
structure (23)
composition (35)
disease (4)
reference (5)
site (14)
peptide (23)
- Homo sapiens (Human)
Taxonomy
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Low-Density Lipoprotein Particle (GO_0034362)
Source
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-3)[Gal(b1-?)GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[Gal(b1-?)GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[Gal(b1-?)GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-?)Man(a1-3)[NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-3)[NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-6)[Gal(b1-?)GlcNAc(b1-?)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-?)GlcNAc(b1-?) + NeuAc(a2-3) + NeuAc(a2-6)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-?)[Man(a1-?)]Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-?)[Man(a1-?)]Man(a1-?)[Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-?)[Man(a1-?)]Man(a1-?)[Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man(a1-?)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-?)[Man(a1-?)]Man(a1-?)[Man(a1-?)Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man(a1-?)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-?)Man(a1-?)[Man(a1-?)Man(a1-?)]Man(a1-?)[Man(a1-?)Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Hybrid / Man(a1-?)[Man(a1-?)]Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Hybrid / Man(a1-?)[Man(a1-?)]Man(a1-?)[Gal(b1-?)GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Hybrid / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
Reported structure
- Hex:4 HexNAc:3 (avg mass : 1276.1699 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:6 (avg mass : 1885.7549 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 (avg mass : 1600.4547 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 (avg mass : 3172.9044 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:6 dHex:2 NeuAc:4 (avg mass : 3829.4997 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
Composition
- Cancer, breast (DOID:1612)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
- Prostate cancer (DOID:10283)
Disease
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles. (2001 - Garner B, Harvey DJ, Royle L, Frischmann M, Nigon F, Chapman MJ, Rudd PM) / Status : Reviewed
- High-mannose structure of apolipoprotein-B from low-density lipoproteins of human plasma. (1985 - Vauhkonen M, Viitala J, Parkkinen J, Rauvala H) / Status : Reviewed
Reference
- Apolipoprotein b-100 / Homo sapiens
Reported glycosite
- EEEMLENVSLVCPK (14aa)
- LDTVYGNCSTHFTVK (15aa)
- QVIFIDTVYGNCSTHFTVK (19aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
- SNASSTDSASYYPLTGDTR (19aa)
- QVFPGINYCTSGAYSNASSTDSASYYPITGDTR (33aa)
- QVFPGLNYCTSGAYSNASSTDSASYYPLTGDTR (33aa)
- FNSSYLQGTNQITGR (15aa)
- IQSPLFTLDANADIGNGTTSANEAGIAASITAK (33aa)
- VNQNLVYESGSLNFSK (16aa)
- VNQNLVYESGSLNFSK (16aa)
- VNQNIVYESGSINFSK (16aa)
- SYNETK (6aa)
- ELCTISHIFIPAMGNITYDFSFK (23aa)
- VEGSHNSTVSLTTK (14aa)
- GSHNSTVSLTTKNME (15aa)
- FVEGSHNSTVSITTK (15aa)
- FVEGSHNSTVSLTTK (15aa)
- SKPTVSSSMEFKYDFNSSMLYSTAK (25aa)
- YDFNSSMLYSTAK (13aa)
- YDFNSSMIYSTAK (13aa)
- FEVDSPVYNATWSASIK (17aa)
- FEVDSPVYNATWSASLK (17aa)
- ENLCLNLHK (9aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1479.3649)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1641.5073)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1770.6228)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1770.6228)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1932.7652)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1932.7652)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Complex (avg mass : 2589.3605)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1235.1173)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1235.1173)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1397.2597)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1397.2597)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1559.4021)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1559.4021)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1721.5445)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1721.5445)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1883.6869)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1883.6869)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Hybrid (avg mass : 1438.3123)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- N-Linked / Hybrid (avg mass : 1600.4547)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid (avg mass : 1729.5702)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
- Apolipoprotein b-100 / Homo sapiens
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-?)[Man(a1-?)]Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- LDTVYGNCSTHFTVK (15aa)
- QVIFIDTVYGNCSTHFTVK (19aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
- FVEGSHNSTVSLTTK (15aa)
-
- Hex:4 HexNAc:3 / N-Linked (avg mass : 1276.1699)
- Blood Serum (UBERON_0001977)
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Mammary Gland (UBERON_0001911)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-?)[Man(a1-?)]Man(a1-?)[Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Cancer, breast (DOID:1612)
- Apolipoprotein b-100 / Homo sapiens
- ELCTISHIFIPAMGNITYDFSFK (23aa)
-
- Hex:5 HexNAc:3 / N-Linked (avg mass : 1438.3123)
- Blood Serum (UBERON_0001977)
- N-Linked / Hybrid / Man(a1-?)[Man(a1-?)]Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
-
- Hex:4 HexNAc:4 / N-Linked (avg mass : 1479.3649)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-?)[Man(a1-?)]Man(a1-?)[Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man(a1-?)"
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- QVIFIDTVYGNCSTHFTVK (19aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- FNSSYLQGTNQITGR (15aa)
- FVEGSHNSTVSLTTK (15aa)
-
- Hex:5 HexNAc:4 / N-Linked (avg mass : 1641.5073)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-3)[Gal(b1-?)GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Apolipoprotein b-100 / Homo sapiens
- FNSSYLQGTNQITGR (15aa)
- FVEGSHNSTVSLTTK (15aa)
- YDFNSSMLYSTAK (13aa)
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-?)[Man(a1-?)]Man(a1-?)[Man(a1-?)Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man(a1-?)"
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- QVIFIDTVYGNCSTHFTVK (19aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
- FVEGSHNSTVSLTTK (15aa)
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- N-Linked / Hybrid / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- FNSSYLQGTNQITGR (15aa)
- FVEGSHNSTVSITTK (15aa)
- FVEGSHNSTVSLTTK (15aa)
- YDFNSSMLYSTAK (13aa)
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1770.6228)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- FNSSYLQGTNQITGR (15aa)
- FVEGSHNSTVSLTTK (15aa)
- YDFNSSMLYSTAK (13aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Blood Serum (UBERON_0001977)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-?)Man(a1-?)[Man(a1-?)Man(a1-?)]Man(a1-?)[Man(a1-?)Man(a1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Apolipoprotein b-100 / Homo sapiens
- QVLFLDTVYGNCSTHFTVK (19aa)
-
- Hex:4 HexNAc:6 / N-Linked (avg mass : 1885.7549)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Apolipoprotein b-100 / Homo sapiens
- YDFNSSMIYSTAK (13aa)
-
- Hex:6 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1891.7126)
- Blood Serum (UBERON_0001977)
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
- YDFNSSMLYSTAK (13aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[Gal(b1-?)GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[Gal(b1-?)GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- QVLFLDTVYGNCSTHFTVK (19aa)
- SNASSTDSASYYPLTGDTR (19aa)
- QVFPGINYCTSGAYSNASSTDSASYYPITGDTR (33aa)
- FNSSYLQGTNQITGR (15aa)
- VNQNLVYESGSLNFSK (16aa)
- VNQNLVYESGSLNFSK (16aa)
- VNQNIVYESGSINFSK (16aa)
- SYNETK (6aa)
- VEGSHNSTVSLTTK (14aa)
- FVEGSHNSTVSITTK (15aa)
- FVEGSHNSTVSLTTK (15aa)
- SKPTVSSSMEFKYDFNSSMLYSTAK (25aa)
- YDFNSSMLYSTAK (13aa)
- YDFNSSMIYSTAK (13aa)
- FEVDSPVYNATWSASIK (17aa)
- FEVDSPVYNATWSASLK (17aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
- GSHNSTVSLTTKNME (15aa)
- YDFNSSMLYSTAK (13aa)
- ENLCLNLHK (9aa)
-
- Hex:4 HexNAc:6 dHex:2 / N-Linked (avg mass : 2178.0409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Apolipoprotein b-100 / Homo sapiens
- VNQNIVYESGSINFSK (16aa)
- FVEGSHNSTVSITTK (15aa)
- FEVDSPVYNATWSASIK (17aa)
-
- Hex:5 HexNAc:6 dHex:1 / N-Linked (avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Apolipoprotein b-100 / Homo sapiens
- FEVDSPVYNATWSASIK (17aa)
-
- Hex:6 HexNAc:6 / N-Linked (avg mass : 2210.0397)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Apolipoprotein b-100 / Homo sapiens
- QVFPGINYCTSGAYSNASSTDSASYYPITGDTR (33aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-?)Man(a1-3)[NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-3)[NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- EEEMLENVSLVCPK (14aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
- QVFPGLNYCTSGAYSNASSTDSASYYPLTGDTR (33aa)
- QVFPGINYCTSGAYSNASSTDSASYYPITGDTR (33aa)
- FNSSYLQGTNQITGR (15aa)
- IQSPLFTLDANADIGNGTTSANEAGIAASITAK (33aa)
- VNQNLVYESGSLNFSK (16aa)
- VNQNLVYESGSLNFSK (16aa)
- VNQNIVYESGSINFSK (16aa)
- ELCTISHIFIPAMGNITYDFSFK (23aa)
- VEGSHNSTVSLTTK (14aa)
- FVEGSHNSTVSITTK (15aa)
- FVEGSHNSTVSLTTK (15aa)
- YDFNSSMLYSTAK (13aa)
- YDFNSSMIYSTAK (13aa)
- FEVDSPVYNATWSASIK (17aa)
- FEVDSPVYNATWSASLK (17aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Apolipoprotein b-100 / Homo sapiens
- FNSSYLQGTNQITGR (15aa)
- FEVDSPVYNATWSASLK (17aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- QVLFLDTVYGNCSTHFTVK (19aa)
- QVFPGINYCTSGAYSNASSTDSASYYPITGDTR (33aa)
- FEVDSPVYNATWSASIK (17aa)
- FEVDSPVYNATWSASLK (17aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- QVLFLDTVYGNCSTHFTVK (19aa)
- VEGSHNSTVSLTTK (14aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- VEGSHNSTVSLTTK (14aa)
- FVEGSHNSTVSLTTK (15aa)
- YDFNSSMLYSTAK (13aa)
- FEVDSPVYNATWSASLK (17aa)
- ENLCLNLHK (9aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2516.3091)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Apolipoprotein b-100 / Homo sapiens
- ENLCLNLHK (9aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-6)[Gal(b1-?)GlcNAc(b1-?)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-?)GlcNAc(b1-?) + NeuAc(a2-3) + NeuAc(a2-6)"
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- QVLFLDTVYGNCSTHFTVK (19aa)
- VEGSHNSTVSLTTK (14aa)
- YDFNSSMLYSTAK (13aa)
- FEVDSPVYNATWSASIK (17aa)
- FEVDSPVYNATWSASLK (17aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
- ENLCLNLHK (9aa)
-
- Hex:6 HexNAc:6 NeuAc:2 / N-Linked (avg mass : 2792.5555)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Apolipoprotein b-100 / Homo sapiens
- VNQNLVYESGSLNFSK (16aa)
- VNQNLVYESGSLNFSK (16aa)
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Apolipoprotein b-100 / Homo sapiens
- QVLFLDTVYGNCSTHFTVK (19aa)
- VEGSHNSTVSLTTK (14aa)
- FEVDSPVYNATWSASIK (17aa)
- FEVDSPVYNATWSASLK (17aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Apolipoprotein b-100 / Homo sapiens
- QVLFLDTVYGNCSTHFTVK (19aa)
- FVEGSHNSTVSLTTK (15aa)
- FEVDSPVYNATWSASLK (17aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 / N-Linked (avg mass : 3172.9044)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3392.0988)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 / N-Linked (avg mass : 3683.3567)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
-
- Hex:7 HexNAc:6 dHex:2 NeuAc:4 / N-Linked (avg mass : 3829.4997)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Apolipoprotein b-100 / Homo sapiens
- FVEGSHNSTVSLTTK (15aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
